Add BrightSurf on Google Email

WIN Consortium leading the future of precision cancer medicine

The WIN Consortium is transforming cancer care through personalized medicine, leveraging AI, molecular profiling, and clinical trials. The organization's innovations, including N-of-1 clinical trials and WINTHER and WINGPO trials, are helping clinicians make more precise treatment decisions and improving outcomes for cancer patients.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateMar 18, 2025

Deep learning revolutionizes cytoskeleton research

A research team at Kumamoto University developed a deep learning-based method for analyzing the cytoskeleton more accurately and efficiently than ever before. This technique enabled more reliable measurements of cytoskeleton density, which is critical for understanding cellular structure and function.

SourceKumamoto University·JournalPROTOPLASMA·TypeExperimental study·DateMar 17, 2025

Stanford Medicine research explores the promise and perils of AI in citizen science

A new study investigates how AI can empower communities to actively participate in scientific research, addressing critical ethical considerations. The research aims to advance health equity and public health outcomes by enhancing citizen science with AI technologies such as conversational AI, generative AI, and predictive analytics.

SourceJMIR Publications·JournalJMIR Public Health and Surveillance·TypeCommentary/editorial·DateMar 13, 2025

New study reveals why students reject ChatGPT feedback in academic writing

A recent study found that 45.9% of ChatGPT-generated feedback was rejected by second-language learners, with content-focused feedback facing higher rejection rates. The researchers identified four key factors driving rejection: misalignment with goals or external standards, and the subjective nature of content-related suggestions.

SourceECNU Review of Education·JournalECNU Review of Education·TypeSurvey·DateMar 10, 2025

Butterfly-inspired 4D printing of smart hydrogels enables precise micro-nano deformation

A Chinese research team has created a single-step femtosecond laser 4D printing technology that enables rapid and precise micro-scale deformation of smart hydrogels. The innovation mimics the hierarchical structure of butterfly wings, promising applications in flexible electronics and minimally invasive medicine.

SourceChinese Academy of Sciences Headquarters·JournalACS Materials Letters·TypeExperimental study·DateMar 5, 2025

Innovations in core-shell nanoparticles advancing drug delivery and precision medicine

Core-shell nanoparticles offer effective drug encapsulation, shielding from degradation, and controlled release. This innovation enables targeted drug delivery, improving treatment outcomes and reducing side effects. The versatility of these nanoparticles allows for tailored materials to suit different therapeutic needs.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalOMICS A Journal of Integrative Biology·TypeLiterature review·DateMar 5, 2025

Study provides novel insights into GenAI feedback

Researchers found that GenAI feedback offers timely and personalized feedback, educational benefits as an essay editor and tutor, and social benefits as a supportive environment. However, challenges include limited AI skills, dependency risk, and emotional understanding limitations.

SourceECNU Review of Education·JournalECNU Review of Education·TypeExperimental study·DateMar 4, 2025

Application of cone-beam computed tomography in interventional therapies for liver malignancy: A consensus statement by the Chinese College of Interventionalists

A consensus statement by the Chinese College of Interventionalists promotes CBCT use in liver malignancy therapies, addressing limitations and challenges. The integration of artificial intelligence and technological innovations are expected to refine CBCT's efficacy and safety.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateFeb 24, 2025

Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells

A synthetic retinoic acid-inducible gene I (RIG-I) agonist RNA has been shown to induce innate immune signaling and death of hepatocellular carcinoma cells in vitro. The addition of recombinant interferon-b potentiated this cell death, suggesting a potential new mechanism for treating patients with liver cancer.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Interferon & Cytokine Research·TypeExperimental study·DateFeb 19, 2025

New study suggests panitumumab with low-dose capecitabine as a safer, effective maintenance treatment for advanced colorectal cancer

Researchers found that a combination of Panitumumab and low-dose Capecitabine is an effective and well-tolerated maintenance regimen for patients with wild-type KRAS metastatic colorectal cancer. The treatment delayed disease progression while managing side effects, improving patients' quality of life.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateFeb 18, 2025

JMIR Publications announces new CEO

Dr. Gunther Eysenbach is stepping down as CEO of JMIR Publications to focus on innovation in academic publishing and AI-driven solutions. Sean Jeong takes over with a proven track record in digital transformation, agile delivery, and program execution.

NewsGuard: Study finds no bias against conservative news outlets

A recent study evaluating NewsGuard's media reliability rating service found no evidence of bias against conservative news outlets. The analysis of over 11,000 sources in nine countries revealed stable trustworthiness scores since 2022, with the US receiving lower ratings due to hyper-partisan sources lacking editorial practices.

SourceComplexity Science Hub·JournalJournal of Quantitative Description Digital Media·TypeData/statistical analysis·DateJan 29, 2025

Anti-correlation between KLRG1 and PD-1 in tumor CD8 T cells

A new study published in Oncotarget discovered an anti-correlation between PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells. This finding suggests the potential for combination therapy to enhance cancer treatment by targeting both markers simultaneously, which could lead to more significant and long-lasting benefits.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateJan 21, 2025

Dose-dependent relationship between alcohol consumption and the risks of hepatitis b virus-associated cirrhosis and hepatocellular carcinoma: A meta-analysis and systematic review

A meta-analysis found a dose-dependent relationship between alcohol consumption and the risks of cirrhosis and HCC in HBV patients, with daily alcohol consumption exceeding 12g increasing risk by 6.2% and 11.5% respectively.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 16, 2025